November 5, 2024 — Alphabet (NASDAQ: GOOGL, GOOG), through Google, has recently achieved a legal victory by defeating a proposed class action lawsuit. The lawsuit accused Google of illegally profiting from Google Play gift card scams and refusing to refund millions of dollars to victims.
November 5, 2024 — Gaxos. ai (NASDAQ: GXAI), an emerging AI applications company, announced its participation in the AI Summit New York, set for Dec.
November 5, 2024 — Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) has announced a proposed private placement aiming to raise up to $750,000 through the issuance of units, each consisting of one common share and a half transferable warrant. Priced at $0.
November 5, 2024 — D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leading quantum computing company, will release its financial results for the third quarter of fiscal year 2024 ended September 30, 2024 on November 14, prior to market opening.
November 4, 2024 — The Benzinga Future of Digital Assets and Fintech Deal Day conference is set to showcase timely insights into the challenges and opportunities shaping the next era of capital markets. The conference will feature 130+ speakers representing the full spectrum of today’s financial landscape.
November 4, 2024 — Blockchain Africa Conference 2024 is slated to take place at the CSIR International Convention Centre in Pretoria (Tshwane) on Nov. 20, 2024.
November 4, 2024 — D-Wave Quantum Inc. (NYSE: QBTS) (“D-Wave”), a leading quantum computing company, will release its financial results for the third quarter of fiscal year 2024 ended September 30, 2024 on November 14, prior to market opening.
November 4, 2024 — Fathom Nickel (CSE: FNI) (FSE: 6Q5) (OTCQB: FNICF) will host a live virtual corporate update with Red Cloud Financial Services on Nov. 6, 2024, at 2 p.
November 4, 2024 — Brera Holdings (NASDAQ: BREA) the only publicly traded multi-club ownership company focused on football, will participate in Sportico’s “Invest in Sports” Conference in New York City on November 4. Brera’s CEO Pierre Galoppi and Head of Investments Maria Xing will join prominent industry leaders, investors, and executives, including Blackstone’s David Blitzer and sports investor Alexis Ohanian, in discussing the evolving dynamics and growth of sports investments.
November 4, 2024 — McEwen Mining (NYSE: MUX) (TSX: MUX) will host a conference call on Wednesday, Nov. 6, 2024, at 11 a.
November 4, 2024 — CNS Pharmaceuticals (NASDAQ: CNSP), focused on innovative cancer therapies for brain and central nervous system cancers, recently participated in a Virtual Investor KOL Connect segment featuring Professor Michael Weller, a renowned neuro-oncologist and National Coordinating Investigator for CNS’s study on Berubicin. During the event, Professor Weller discussed the urgent need for effective treatments in glioblastoma multiforme (“GBM”), exploring how Berubicin could serve as a promising therapy within the current limited treatment landscape for this aggressive brain cancer.
November 1, 2024 — D-Wave Quantum (NYSE: QBTS) (“D-Wave”) has appointed technology leaders John DiLullo, CEO of Deepwatch, and Rohit Ghai, CEO of RSA, to its board of directors as the company executes an aggressive go-to-market strategy designed to drive the rapid adoption of its annealing quantum computing solutions across global businesses, research institutions and government agencies. DiLullo and Ghai bring extensive expertise in accelerating growth and profitability, commercial technology adoption, and digital transformation.
November 1, 2024 — Brera Holdings (NASDAQ: BREA) celebrated UYBA’s resurgence in the Italian Serie A1 league with two successive victories. In their latest match, UYBA won a thrilling straight-set match against Chieri ’76 (25-22, 25-23, 25-23), following an earlier 3-1 triumph over Pallavolo Scandicci.
October 30, 2024 — PayPal Holdings (NASDAQ: PYPL) is a leading player in the digital payments industry, known for its innovative solutions that facilitate online transactions. Originally a pioneer in peer-to-peer payments, PayPal is now focusing on becoming a comprehensive two-sided payments technology platform.
October 30, 2024 — Polyrizon (NASDAQ: PLRZ), a development stage biotech company specializing in the development of innovative medical device hydrogels, has announced the closing of its underwritten initial public offering of 958,903 units at a combined public offering price of $4. 38 per unit.
October 30, 2024 — Mullen Automotive (NASDAQ: MULN) has announced that its subsidiary, Bollinger Motors, has delivered three Bollinger B4 electric trucks to TEC Equipment locations across Washington and California. The 2025 Bollinger B4, an all-electric Class 4 chassis cab truck built for commercial use, aims to support fleet electrification efforts on the West Coast, marking a milestone with TEC Equipment as a new dealer.
October 29, 2024 — Emperor Metals (CSE: AUOZ) (OTCQB: EMAUF) (FRA:9NH) has released initial results from its 2024 drilling campaign at the Duquesne West Gold Project, revealing promising potential for resource expansion in its open-pit model. The first three holes of the 19-hole program intersected significant low-grade gold mineralization near surface, with highlights including 52.
October 29, 2024 — Mullen Automotive (NASDAQ: MULN) announced that Bollinger Motors founder, Robert Bollinger, has provided $10 million in non-dilutive debt financing to accelerate the production and sales of Bollinger’s all-electric Class 4 B4 truck. This funding supports Bollinger’s full-scale production efforts, with trucks now assembled by Roush Industries in Michigan, using over 70% U.
October 29, 2024 — Aditxt (NASDAQ: ADTX) has appointed Sylvia Hermina to its Board of Directors, adding over 20 years of expertise in corporate governance, M&A, and shareholder relations to its leadership. As a Senior VP at Kingsdale Advisors, Hermina has played a key role in the firm’s U.
October 29, 2024 — Tonix Pharmaceuticals (NASDAQ: TNXP), a biopharmaceutical company advancing treatments across multiple therapeutic areas, announced that CEO Seth Lederman, M. D.